Admac Lifesciences Limited
About Admac Lifesciences Limited
Data last updated:
Admac Lifesciences Limited is a public limited company based in Panchkula, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 July 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U21009HR2023PLC113083.
The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹11.74 Cr. It is led by directors including Nilesh Batra and Rakesh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sector 5, Panchkula, Haryana.
As per MCA filings, the company has open charges of ₹51.88 Cr on record.
Company details
Contact details
Admac Lifesciences Limited's registered office is in Panchkula, Haryana.
- Registered Address2nd Floor SCO 84, Sector 5 Urban Estate, Panchkula, Haryana, India – 134109
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Admac Lifesciences Limited
FY 2025 filings availableAdmac Lifesciences Limited reported revenue of ₹764 for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2023-24 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Admac Lifesciences Limited, buy the company report.
Board of directors of Admac Lifesciences Limited
Admac Lifesciences has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nilesh Batra | Director | 06 Jul 2023 | 3 Years 3 Months | Current |
| Rakesh Kumar | Director | 06 Jul 2023 | 3 Years 3 Months | Current |
| Ramesh Chand Sharma | Director | 06 Jul 2023 | 3 Years 3 Months | Current |
Peer comparison
Admac Lifesciences Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations, Lifesciences), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hans Pharmaceutical and Chemicals Private Limited | ₹1,000 (FY 2019) | Uttar Pradesh, India | ||||
| Reckitt Piramal Private Limited | ₹1,000 (FY 2025) | -100.0% | Mumbai, Maharashtra, India | |||
| Zorticos Lifesciences Private Limited | ₹900 (FY 2020) | -100.0% | Mira Road, Maharashtra, India | |||
| Elyon Health Care Private Limited | ₹899 (FY 2024) | 6.0% | Navi Mumbai, Maharashtra, India | |||
| Megan Lifesciences Private Limited | ₹810 (FY 2025) | Ahmedabad, Gujarat, India | ||||
| Admac Lifesciences Limitedthis company | ₹764 (FY 2024) | Panchkula, Haryana, India | ||||
| Hathway Wellness Private Limited | ₹752 (FY 2024) | Nagpur, Maharashtra, India | ||||
| Lufran Pharma Private Limited | ₹740 (FY 2025) | Lucknow, Uttar Pradesh, India | ||||
| Rangacharya Industries Private Limited | ₹650 (FY 2024) | Navi Mumbai, Maharashtra, India | ||||
| Ochoa Laboratories Limited | ₹605 (FY 2025) | New Delhi, Delhi, India | ||||
| Maitri Healthcare and Traders Private Limited | ₹604 (FY 2017) | -98.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Admac Lifesciences Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Jul 2025 | 101140057 | Hdfc Bank Limited | ₹50.31 Cr | Open | |
| 10 Jul 2025 | 101129027 | Others | ₹1.57 Cr | Open |
To see the full charge records of Admac Lifesciences Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Admac Lifesciences Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Admac Lifesciences Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Admac Lifesciences Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Admac Lifesciences Limited has 4 board changes on record since 2023: 4 appointments. The latest: Nilesh Batra was appointed as Director on 06 Jul 2023.
Frequently asked questions
Admac Lifesciences is an active public limited company based in Panchkula, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 July 2023 (3+ years old) and is registered under CIN U21009HR2023PLC113083.
Admac Lifesciences has 3 current directors:
- Nilesh Batra - Director
- Rakesh Kumar - Director
- Ramesh Chand Sharma - Director
The latest financial statements of Admac Lifesciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Admac Lifesciences is U21009HR2023PLC113083. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Admac Lifesciences was incorporated on 06 July 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Admac Lifesciences by revenue are Hans Pharmaceutical and Chemicals Private Limited, Reckitt Piramal Private Limited, Zorticos Lifesciences Private Limited, Elyon Health Care Private Limited, Megan Lifesciences Private Limited and 5 more, all in the Pharma industry (Formulations, Lifesciences).
Nilesh Batra was appointed as Director on 06 Jul 2023. Rakesh Kumar was appointed as Director on 06 Jul 2023. Ramesh Chand Sharma was appointed as Director on 06 Jul 2023. Admac Lifesciences has 4 board changes on record in total.
The registered office of Admac Lifesciences is at 2nd Floor SCO 84, Sector 5 Urban Estate, Panchkula, Haryana, India – 134109.
Admac Lifesciences operates in the pharma industry, in the drug formulation and development segment.
Admac Lifesciences has open charges of ₹51.88 Cr and no satisfied charges on record as per latest MCA filings.
Admac Lifesciences can be reached at its registered office: 2nd Floor SCO 84, Sector 5 Urban Estate, Panchkula, Haryana, India – 134109.